Transmutex’s CHF 5.3 Million Series A Financing Round

Lenz & Staehelin advised Transmutex on the deal.

The Geneva based cleantech company Transmutex has completed its CHF 5.3 million Series A. This comes a couple months after its CHF 2.6 million seed financing round that completed in May. These financing rounds will allow Transmutex to continue its R&D activities.

Transmutex is a start-up founded in Geneva in 2019, developing a revolutionary nuclear technology for the transmutation of long-lived nuclear waste based on CERN technologies. Transmutex’s solution uses particle accelerators to transmute existing long-lived nuclear waste, which, in turn, produces carbon-free energy that can be reinjected in the grid or used to produce green hydrogen. In 2020, Transmutex was awarded the public vote, in the cleantech category, at the 2020 Top 100 Swiss Startups Award organized by Venturelab.

The Lenz & Staehelin team was led by Benoît Merkt (Picture – Commercial and Contracts), Sevan Antreasyan (Intellectual Property, Commercial and Contracts), Federico Trabaldo Togna and Ralph Kaufmann (both Corporate and M&A) and included Floran Ponce and Didier Nsanzineza (Tax), Alix Lauener (Corporate and M&A), and Prisca Cattaneo (Employment and Pensions).

Involved fees earner: Sevan Antreasyan – Lenz & Staehelin; Prisca Cattaneo – Lenz & Staehelin; Ralph Kaufmann – Lenz & Staehelin; Alix Lauener – Lenz & Staehelin; Benoît Merkt – Lenz & Staehelin; Didier Nsanzineza – Lenz & Staehelin; Floran Ponce – Lenz & Staehelin; Federico Trabaldo Togna – Lenz & Staehelin;

Law Firms: Lenz & Staehelin;

Clients: Transmutex;

Author: Federica Tiefenthaler